Impact of Minimal Residual Negativity using Next Generation Flow Cytometry on Outcomes in Light Chain Amyloidosis

We evaluated bone marrow minimal residual disease (MRD) negativity in 44 patients with light chain (AL) amyloidosis using next generation flow cytometry (sensitivity ≥ 1× 10(−5); median events analyzed: 8.7 million, range: 4.8 to 9.7 million). All patients underwent MRD testing in two years from sta...

詳細記述

保存先:
書誌詳細
出版年:Am J Hematol
主要な著者: Sidana, Surbhi, Muchtar, Eli, Sidiqi, M.Hasib, Jevremovic, Dragan, Dispenzieri, Angela, Gonsalves, Wilson, Buadi, Francis, Lacy, Martha Q., Hayman, Suzanne R., Kourelis, Taxiarchis, Kapoor, Prashant, Go, Ronald S., Warsame, Rahma, Leung, Nelson, Rajkumar, S.Vincent, Kyle, Robert A., Gertz, Morie A., Kumar, Shaji K.
フォーマット: Artigo
言語:Inglês
出版事項: 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8019396/
https://ncbi.nlm.nih.gov/pubmed/32010993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25746
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料